Entity Common Stock, Shares Outstanding of Allogene Therapeutics, Inc. from 15 Nov 2018 to 04 Nov 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Allogene Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 15 Nov 2018 to 04 Nov 2025.
  • Allogene Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 04 Nov 2025 was 224,730,144, a 7.2% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Allogene Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 224,730,144 +15,058,053 +7.2% 04 Nov 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 221,881,029 +12,769,513 +6.1% 11 Aug 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 217,264,738 +48,172,746 +28% 07 Mar 2025 10-K 13 Mar 2025 2024 FY
Q3 2024 209,672,091 +41,395,429 +25% 01 Nov 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 209,111,516 +41,485,151 +25% 02 Aug 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 169,091,992 +23,250,372 +16% 12 Mar 2024 10-K 14 Mar 2024 2023 FY
Q3 2023 168,276,662 +24,066,508 +17% 31 Oct 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 167,626,365 +23,819,540 +17% 31 Jul 2023 10-Q 02 Aug 2023 2023 Q2
Q1 2023 145,841,620 +2,241,306 +1.6% 01 May 2023 10-Q 03 May 2023 2023 Q1
Q3 2022 144,210,154 +1,694,216 +1.2% 31 Oct 2022 10-Q 02 Nov 2022 2022 Q3
Q2 2022 143,806,825 +1,623,407 +1.1% 05 Aug 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 143,600,314 +2,061,893 +1.5% 02 May 2022 10-Q 04 May 2022 2022 Q1
Q3 2021 142,515,938 +2,235,786 +1.6% 02 Nov 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 142,183,418 +2,891,900 +2.1% 02 Aug 2021 10-Q 04 Aug 2021 2021 Q2
Q1 2021 141,538,421 +16,206,926 +13% 03 May 2021 10-Q 05 May 2021 2021 Q1
Q3 2020 140,280,152 +18,378,051 +15% 02 Nov 2020 10-Q 04 Nov 2020 2020 Q3
Q2 2020 139,291,518 +17,542,537 +14% 03 Aug 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 125,331,495 +3,848,824 +3.2% 04 May 2020 10-Q 06 May 2020 2020 Q1
Q3 2019 121,902,101 01 Nov 2019 10-Q 05 Nov 2019 2019 Q3
Q2 2019 121,748,981 02 Aug 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 121,482,671 04 Mar 2019 10-K 08 Mar 2019 2018 FY
Q4 2018 121,482,671 15 Nov 2018 10-Q 21 Nov 2018 2018 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.